Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Bavarian Nordic — Februar 2019

Planlagt Fastgjort Låst Flyttet Bavarian Nordic
24 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #1

    Pharm-Olam Enrolls Patients in Zealand Pharma Orphan Drug Study (SBS)

    (February 05, 2019 08:05 AM Eastern Standard Time)

    https://www.businesswire.com/news/home/20190205005137/en/Pharm-Olam-Enrolls-Patients-Zealand-Pharma-Orphan-Drug

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #2

      På trods af at dax'en falder og er nede med omkring -2% i dag, så fortsætter Nordea ufortrødent med at købe Zealand Pharma.

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #3

        Sanofi oplyser at Zealand Pharma's tidligere kombinationspræparat Soliqua går frem med +188.9% i Q4 2018.

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #4

          Ny analyse video:

          ALK-abello,
          Ambu
          Bavarian
          Carlsberg

          http://www.proinvestor.com/debat/76692

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #5

            Der må da snart komme nyt mht. den nye CEO eller fx en partneraftale på Dasiglucagon ready-to-use superior rescue pennen.

            1 Reply Last reply
            0
            • K Offline
              K Offline
              kkjoel
              wrote on sidst redigeret af
              #6

              YESS! Endnu en vaccine med Jansen

              1 Reply Last reply
              0
              • K Offline
                K Offline
                kkjoel
                wrote on sidst redigeret af
                #7

                Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen.

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  kkjoel
                  wrote on sidst redigeret af
                  #8

                  startes op i PhI/II...

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    kkjoel
                    wrote on sidst redigeret af
                    #9

                    http://www.bavarian-nordic.com/investor/news/news.aspx?news=5570

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      kkjoel
                      wrote on sidst redigeret af
                      #10

                      MVA-BN HPV is a new vaccine candidate, designed for Janssen as part of the development of a prime-boost vaccine regimen with Janssen’s AdVac technology. The prime-boost vaccine is targeting HPV and represents a novel approach for early treatment and interception of HPV-induced cancers The long-term goal is to develop a vaccine to treat chronic HPV infections as well as prevent precancerous stages of HPV-induced cancer.

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        kkjoel
                        wrote on sidst redigeret af
                        #11

                        With over 300 million estimated infections among men and women annually, HPV (human papillomavirus) is the most prevalent sexually transmitted disease in the world.

                        HPV is the primary cause of cervical cancer and certain types of head and neck cancer, in addition to a number of more rare cancers. Although vaccines have become available to protect against various high-risk HPV subtypes that can cause cancer, there is an unmet need for a therapeutic approach for chronic infections that may lead

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          kkjoel
                          wrote on sidst redigeret af
                          #12

                          to precancerous cell changes. It is estimated, that high-risk HPV types cause approximately 5 percent of all cancers worldwide.

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            kkjoel
                            wrote on sidst redigeret af
                            #13

                            http://www.bavarian-nordic.com/pipeline/mva-bn-hpv.aspx

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              kkjoel
                              wrote on sidst redigeret af
                              #14

                              Stort marked hvis de lykkes! Forsøget har Primary Completion Date: August 9, 2020, så lidt tid endnu tager det da...

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                kkjoel
                                wrote on sidst redigeret af
                                #15

                                ClinicalTrials.gov

                                favicon

                                (clinicaltrials.gov)

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  BioBio
                                  wrote on sidst redigeret af
                                  #16

                                  HPV samarbejdet med Janssen er ikke en nyhed. De er faktisk sent på den, ud fra hvad der tidligere er blevet meldt ud, så man kan sige, at det er fint, at de kom i gang.

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    kkjoel
                                    wrote on sidst redigeret af
                                    #17

                                    Javel - og hvad er det de tidligere har meldt ud om timeframe...?

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      BioBio
                                      wrote on sidst redigeret af
                                      #18

                                      Opstart i H2 2018: http://www.bavarian-nordic.com/media/273834/2018-q3-en.pdf

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #19

                                        Sent på den... tjo, tja, et par måneder fra eller til... i biotek-klinik-tidsskala.. er vist at puste en fjer op til 5 høns på taget.. 😉

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #20

                                          I øvrigt tror jeg vi vil se et fint nyheds-/forsøgsdata-momentum bygge op i løbet af 19, så er meget positiv på BAVA lige nu. De har en virusbaseret leveringsteknologi, der virkelig kan noget særligt. Flere meget interessante stoffer. Om godt 1 år har de osse en stor og hyper moderne fabrikationsfacilitet (betalt af den amerikanske regering... ref. Trump, der ville have Mexico til at betale for muren. Hi hi...), som formentlig ikke findes mage mange steder.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger